FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986848880> ?p ?o ?g. }

• W2986848880 abstract "Abstract Background To report a new standardized cognitive fusion technique on transperineal targeted biopsy (TB) of prostate, and to evaluate its efficacy for cancer detection combined with systematic biopsy (SB) . Methods We present a retrospective review of consecutive patients undergoing multiparametric magnetic resonance (mpMRI) imaging of the prostate with subsequent transperineal prostate biopsy from January 2016 to December 2018. A free-hand 12-core SB was performed for each patient. PI-RADS 3–5 lesions were further targeted for biopsy with our TB technique. Firstly, a central point of suspicious lesion (B′) was registered cognitively on a transverse section of transrectal ultrasound (TRUS). Then, biopsy gun punctured vertically through a fixed pioneer site (A) on skin of perineum, and deep into the TRUS section to get A’. Next, targeted site (B), the surface-projection of B′, would be determined on skin of perineum by A and distance from B′ to A’. Finally, puncture through B to reach B′. Pathological findings of SB and TB were analyzed. Results A total of 126 patients underwent transperineal prostate biopsy (47 SB only, 79 SB + TB). The age of the patients was 68.7 ± 9.2 years. The median preoperative PSA value was 11.8 ng/mL. Preoperative prostate volume was 60.5 ± 50.0 mL. The numbers of patients with PI-RADS scores of 1 through 5 were 4, 43, 27, 21 and 31, respectively. The overall detection rate of cancer was 61/126 (48.4%), and it was significantly higher in the combination cohort (56/79, 70.9%) compared with the SB only cohort (5/47, 10.6%, p <0.001). When focused on the combination cohort, TB detected a similar overall rate of PCa (53/79, 67.1% vs 52/79, 65.8%; p = 0.87) compared with SB. The clinically significant PCa (csPC) detection rate was 52/79 (65.8%), while for TB and SB the csPC/PC rate was 51/53 (96.2%) and 48/52 (92.3%), respectively( p = 0.44). TB demonstrated a better sampling performance (positive rate for each core) compared with SB (51.0% vs 31.3%, p < 0.001). Conclusions Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate has a good efficacy in detecting PCa." @default.
• W2986848880 created "2019-11-22" @default.
• W2986848880 creator A5002968157 @default.
• W2986848880 creator A5026107379 @default.
• W2986848880 creator A5027168766 @default.
• W2986848880 creator A5028702225 @default.
• W2986848880 creator A5031102427 @default.
• W2986848880 creator A5051932390 @default.
• W2986848880 creator A5057909367 @default.
• W2986848880 creator A5065833376 @default.
• W2986848880 creator A5073216396 @default.
• W2986848880 creator A5073688692 @default.
• W2986848880 creator A5090416648 @default.
• W2986848880 date "2019-11-04" @default.
• W2986848880 modified "2023-09-27" @default.
• W2986848880 title "Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate" @default.
• W2986848880 cites W1553221624 @default.
• W2986848880 cites W1571849492 @default.
• W2986848880 cites W2003601241 @default.
• W2986848880 cites W2062305425 @default.
• W2986848880 cites W2080725537 @default.
• W2986848880 cites W2272450061 @default.
• W2986848880 cites W2272984102 @default.
• W2986848880 cites W2301519626 @default.
• W2986848880 cites W2511949746 @default.
• W2986848880 cites W2517499281 @default.
• W2986848880 cites W2537347927 @default.
• W2986848880 cites W2575802248 @default.
• W2986848880 cites W2620670777 @default.
• W2986848880 cites W2731796198 @default.
• W2986848880 cites W2748905777 @default.
• W2986848880 cites W2765743686 @default.
• W2986848880 cites W2771625989 @default.
• W2986848880 cites W2775782740 @default.
• W2986848880 cites W2781525129 @default.
• W2986848880 cites W2789525724 @default.
• W2986848880 cites W2904234367 @default.
• W2986848880 cites W2906950336 @default.
• W2986848880 cites W2984618757 @default.
• W2986848880 doi "https://doi.org/10.1186/s12894-019-0535-8" @default.
• W2986848880 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6830008" @default.
• W2986848880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31684917" @default.
• W2986848880 hasPublicationYear "2019" @default.
• W2986848880 type Work @default.
• W2986848880 sameAs 2986848880 @default.
• W2986848880 citedByCount "3" @default.
• W2986848880 countsByYear W29868488802021 @default.
• W2986848880 countsByYear W29868488802022 @default.
• W2986848880 crossrefType "journal-article" @default.
• W2986848880 hasAuthorship W2986848880A5002968157 @default.
• W2986848880 hasAuthorship W2986848880A5026107379 @default.
• W2986848880 hasAuthorship W2986848880A5027168766 @default.
• W2986848880 hasAuthorship W2986848880A5028702225 @default.
• W2986848880 hasAuthorship W2986848880A5031102427 @default.
• W2986848880 hasAuthorship W2986848880A5051932390 @default.
• W2986848880 hasAuthorship W2986848880A5057909367 @default.
• W2986848880 hasAuthorship W2986848880A5065833376 @default.
• W2986848880 hasAuthorship W2986848880A5073216396 @default.
• W2986848880 hasAuthorship W2986848880A5073688692 @default.
• W2986848880 hasAuthorship W2986848880A5090416648 @default.
• W2986848880 hasBestOaLocation W29868488801 @default.
• W2986848880 hasConcept C121608353 @default.
• W2986848880 hasConcept C126322002 @default.
• W2986848880 hasConcept C126838900 @default.
• W2986848880 hasConcept C126894567 @default.
• W2986848880 hasConcept C141071460 @default.
• W2986848880 hasConcept C143409427 @default.
• W2986848880 hasConcept C167135981 @default.
• W2986848880 hasConcept C2775934546 @default.
• W2986848880 hasConcept C2776235491 @default.
• W2986848880 hasConcept C2780002838 @default.
• W2986848880 hasConcept C2780192828 @default.
• W2986848880 hasConcept C2781163205 @default.
• W2986848880 hasConcept C2781217009 @default.
• W2986848880 hasConcept C2989005 @default.
• W2986848880 hasConcept C71924100 @default.
• W2986848880 hasConceptScore W2986848880C121608353 @default.
• W2986848880 hasConceptScore W2986848880C126322002 @default.
• W2986848880 hasConceptScore W2986848880C126838900 @default.
• W2986848880 hasConceptScore W2986848880C126894567 @default.
• W2986848880 hasConceptScore W2986848880C141071460 @default.
• W2986848880 hasConceptScore W2986848880C143409427 @default.
• W2986848880 hasConceptScore W2986848880C167135981 @default.
• W2986848880 hasConceptScore W2986848880C2775934546 @default.
• W2986848880 hasConceptScore W2986848880C2776235491 @default.
• W2986848880 hasConceptScore W2986848880C2780002838 @default.
• W2986848880 hasConceptScore W2986848880C2780192828 @default.
• W2986848880 hasConceptScore W2986848880C2781163205 @default.
• W2986848880 hasConceptScore W2986848880C2781217009 @default.
• W2986848880 hasConceptScore W2986848880C2989005 @default.
• W2986848880 hasConceptScore W2986848880C71924100 @default.
• W2986848880 hasIssue "1" @default.
• W2986848880 hasLocation W29868488801 @default.
• W2986848880 hasLocation W29868488802 @default.
• W2986848880 hasLocation W29868488803 @default.
• W2986848880 hasLocation W29868488804 @default.
• W2986848880 hasOpenAccess W2986848880 @default.
• W2986848880 hasPrimaryLocation W29868488801 @default.
• W2986848880 hasRelatedWork W1725314107 @default.
• W2986848880 hasRelatedWork W1979374145 @default.

• next